Luigi Valdenassi, Marianna Chierchia, Sergio Pandolfi, Debora Bellardi, Salvatore Chirumbolo, Marianno Franzini
Clinical rheumatology 2024 JunKnee osteoarthritis (knee OA), commonly known as gonarthrosis, is a chronic pathology involving knee at the joint level causing progressive pain, stiffness and difficulty in ambulation and leg movements. So far in situ infiltration therapies such as platelet rich plasma, conditioned autologous serum or hyaluronic acid, provided some encouraging though limited hopes for a routinely recommended therapy for knee OA. Recent clinical successful observations about the use of whole autologous blood ozonated with a calibrated mixture of oxygen and ozone, has promoted the present research study, in order to treat knee OA. A number of 250 patients suffering with knee OA of different Ahlback scores, were treated with infiltration of ozonated blood and evaluated for their WOMAC and Lequesne indexes, pre- and post-treatment, to evaluate pain, disability and stiffness. Patients recovered about 50% of their health status, reducing pain, stiffness and disability by only 5 sessions, one/week, with 20 μg/ml O3 ozonated autologous blood knee infiltrations. The evidence asks for further supporting results yet encourages our efforts to go ahead in this research issue. Key Points •The oxygen-ozone therapy via ozonated blood infiltration was used in this study. •Ozone reduced pain, disability, and stiffness in both female and male patients. •The treatment with ozone improved WOMAC both in type I and type II Ahlback knee OA. •The oxygen-ozone therapy via ozonated blood ameliorated Lequesne functional index. © 2024. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Luigi Valdenassi, Marianna Chierchia, Sergio Pandolfi, Debora Bellardi, Salvatore Chirumbolo, Marianno Franzini. Adjunct treatment with ozone to enhance therapy of knee osteoarthritis: preliminary results. Clinical rheumatology. 2024 Jun;43(6):2093-2101
PMID: 38671261
View Full Text